Screener
Medtronic MDT Neuroscience — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Medtronic’s 10-K, filed June 18, 2026.
- Filed
- Jun 18, 2026, 4:27 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-044354
| (in millions) | Worldwide / Fiscal Year / 2026 | Worldwide / Fiscal Year / 2025 | Worldwide / Fiscal Year / 2024 |
|---|---|---|---|
| Cranial & Spinal Technologies | 5,222 | 4,973 | 4,756 |
| Specialty Therapies | 2,997 | 2,940 | 2,905 |
| Neuromodulation | 2,068 | 1,932 | 1,746 |
| Neuroscience | 10,287 | 9,846 | 9,406 |
| Surgical & Endoscopy | 6,764 | 6,498 | 6,508 |
| Acute Care & Monitoring | 2,051 | 1,909 | 1,908 |
| Medical Surgical | 8,815 | 8,407 | 8,417 |
| Reportable segment net sales | 33,079 | 30,734 | 29,654 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Medtronic's neuroscience — net sales?
- Medtronic (MDT) reported neuroscience — net sales of $2.75B in Q1 2026.
- How has Medtronic's neuroscience — net sales changed year-over-year?
- Medtronic's neuroscience — net sales increased by 5.0% year-over-year, from $2.62B to $2.75B.
- What is the long-term trend for Medtronic's neuroscience — net sales?
- Over 4 years (2022 to 2026), Medtronic's neuroscience — net sales has grown at a 4.0% compound annual growth rate (CAGR), from $8.78B to $10.29B.
- What does neuroscience — net sales mean?
- This represents the total revenue generated from the sale of neuroscience-related medical devices, net of returns, allowances, and discounts. It reflects the market demand and competitive positioning of the segment's product portfolio.
Ask your AI about Medtronic's neuroscience — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude